HIMS Lecture 24 September 2025
PhD presentations by Jelle Hofman and Jonas Djossou. Invited speaker: Prof. Laura Elo (University of Turku)
Event details from: HIMS Lecture 24 September 2025
- Date
- 24 September 2025
- Time
- 11:00 – 13:00
Venue
SP C1.112
Host
Garry Corthals
PhD lectures
11:00 - Lecture 1
Jelle Hofman (Slootweg group)
Title: Investigating a novel route towards R3P=N=[ED]+ species using R3P=N+ Lewis acids
11:15 - Lecture 2
Jonas Djossou (Noël group)
Title: Rapid Methylation of Aryl Bromides Using Air-Stable DABCO-Bis(Trimethylaluminum) via Nickel Metallaphotoredox Catalysis
Invited speaker
Prof. Laura Elo (University of Turku)
Title: Computational tools for proteome-based disease profiling
Abstract
Computational techniques are playing an increasingly important role in biomedical research by enabling the interpretation of complex molecular and clinical data and the generation of novel insights into individual disease and treatment risks. One promising opportunity lies in the re-analysis of existing publicly available datasets using advanced statistical and machine learning approaches for new discoveries. To ensure reliable findings that can ultimately support clinical applications in diagnostics and therapy, reproducibility remains a critical area.
Proteomics has emerged as a powerful tool for biomarker discovery and the investigation of disease mechanisms, providing a more direct measure of the phenotype than genetic information. The development of new computational tools, like deep learning based de novo sequencing, is moving the interpretation of mass spectrometry proteome profiling data to a new level. At the same time, technological advances are expanding the depth of proteome analyses. Single-cell approaches provide detailed insights into cellular heterogeneity, while metaproteomic methods allow functional characterization of complex microbial communities, such as the human gut microbiome. Applying these tools in biomedical studies of diseases, such as type 1 diabetes or breast cancer, enables the identification of new biomarker candidates and new insights into underlying biological pathways.
Selected publications
Moulder R*, Hirvonen MK*, Välikangas T*, Suomi T, Overbergh L, Peakman M, Brunak S, Mathieu C, Knip M, Elo LL*, Lahesmaa R*. Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease. Diabetologia 68(6):1108-1114, 2025. doi: 10.1007/s00125-025-06394-7
Van Den Bossche T, Beslic D, van Puyenbroeck S, Suomi T, Holstein T, Martens L, Elo LL*, Muth T*. Metaproteomics beyond databases: addressing the challenges and potentials of de novo sequencing. Proteomics e202400321, 2025. doi: 10.1002/pmic.202400321
Välikangas T, Suomi T, Chandler CE, Scott AJ, Tran BQ, Ernst RK, Goodlett DR, Elo LL. Benchmarking tools for detecting longitudinal differential expression in proteomics data allows establishing a robust reproducibility optimization regression approach. Nat Commun 13(1):7877, 2022. doi: 10.1038/s41467-022-35564-z
Pietilä S*, Suomi T*, Elo LL. Introducing untargeted data-independent acquisition for metaproteomics of complex microbial samples. ISME Commun 2(1):51, 2022. doi: 10.1038/s43705-022-00137-0
Bio
Laura Elo, PhD, is Professor of Computational Medicine and Research Director in Bioinformatics at Turku Bioscience Centre and Faculty of Medicine, University of Turku. She leads the Turku Medical Bioinformatics Centre (https://elolab.utu.fi). Her research focuses on developing computational methods and models for interpreting high-throughput omics and digital health data. Using statistical modelling and machine learning, her group has, for example, identified early markers for type 1 diabetes and developed several powerful computational models for predicting disease and treatment risks. She has published over 180 peer-reviewed articles and more than 25 software packages in the field.
